Aplix FCF per Share
The Free Cash Flow per Share of Aplix (3727.T) as of Aug 17, 2026 is 9.05 JPY. In the previous year, Free Cash Flow per Share was 8.05 JPY — a change of 12.37% (higher).
Get this data via API
Financial Data API
FCF per Share
9.05JPY
YoY
12.37%
Last updated:
Free Cash Flow per Share of Aplix is 2026 9.05 JPY. Free Cash Flow per Share of Aplix was 2025 8.05 JPY. It decreases by 12.37% higher compared to the previous year.
Access this data via the Eulerpool API
Aplix Stock analysis
What does Aplix do? Aplix Corp is a leading developer and manufacturer of innovative technology solutions. The company is based in Japan and was originally founded in 1986 as a software development company. Since then, it has evolved into an internationally active company specializing in the development of software, hardware, and other electronics products.
One of the company's main divisions is the development of software systems and applications. Aplix utilizes a wide range of operating systems and technologies, including Windows, Linux, Android, and iOS. The company is known for its cross-platform development and distribution solutions, as well as its mobile computer software that runs on a variety of mobile devices.
In addition to software systems, the company also offers hardware products, including digital cameras and other electronic devices. These devices are used in a variety of applications, from leisure and sports photography to surveillance and security. Aplix has also developed defined industry solutions, such as medical devices and transportation technology.
Another important area of Aplix is the development and manufacturing of textiles and other accessories for the fashion industry. The company utilizes versatile technologies and products to develop innovative solutions in this field. For example, the company has developed the use of "smart fabrics" that are equipped with embedded and wireless sensors and are wearable. These products, for instance, serve as fitness and health trackers.
Aplix has also focused on providing solutions for the healthcare industry. The company has developed a wide range of products that help improve medical care by facilitating the diagnosis and treatment of diseases. For example, Aplix has developed wearable devices that can monitor blood pressure and heart rate. There are also ongoing projects in the development of telemedicine applications.
In recent times, the company has built strong collaborations in the field of artificial intelligence to leverage the technology in supporting high-tech platforms and applications. The company plans to integrate these technologies into various areas within the company to develop innovative solutions.
Overall, Aplix has established itself as an innovative company specializing in diverse industries and requirements. Since its founding, the company has built footholds in various areas and has filed a significant number of patents over the years. All of these have contributed to the company's strong presence in software development, hardware, and critical-textile business today. Aplix is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Aplix stock
Free Cash Flow per Share of Aplix is 9.05 JPY in 2026.
Free Cash Flow per Share of Aplix changed from 8.05 JPY to 9.05 JPY, representing a 12.37% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Aplix since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
Cash Flow — Aplix
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Aplix
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth